Co-Authors
This is a "connection" page, showing publications co-authored by ABOU BAKR SALAMA and RIHAM ABOULEISA.
Connection Strength
2.211
-
Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure. Int J Mol Sci. 2021 Jul 19; 22(14).
Score: 0.724
-
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity. NPJ Regen Med. 2025 Jan 11; 10(1):1.
Score: 0.230
-
Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats. Cardiovasc Res. 2024 03 13; 120(2):152-163.
Score: 0.218
-
Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity. Res Sq. 2023 Nov 30.
Score: 0.213
-
A novel small molecule inhibitor of p38? MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation. Br J Pharmacol. 2023 12; 180(24):3271-3289.
Score: 0.210
-
Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model. Mol Cell Biochem. 2023 Jun; 478(6):1245-1250.
Score: 0.198
-
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure. Circulation. 2022 04 26; 145(17):1339-1355.
Score: 0.188
-
Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activation. Redox Biol. 2021 10; 46:102094.
Score: 0.182
-
Biomimetic cardiac tissue culture model (CTCM) to emulate cardiac physiology and pathophysiology ex vivo. Commun Biol. 2022 09 09; 5(1):934.
Score: 0.049